• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


93.317 EUR 1.122 1.19%

As of 15:35:02 ET on 12/23/2014.

Snapshot for Biotest AG (BIO3)

Open: 94.570 Day's Range: 93.116 - 95.090 Volume: 6,570
Previous Close: 94.439 52wk Range: 69.010 - 100.000 1-Yr Rtn: +23.09%

Stock Chart for BIO3

No chart data available.
  • BIO3:GR 93.235
  • 1D
  • 1M
  • 1Y
Interactive BIO3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIO3

Current P/E Ratio (ttm) 44.4367
Estimated P/E(12/2014) 39.8791
Relative P/E vs. DAX 2.5535
Earnings Per Share (EUR) (ttm) 2.1000
Est. EPS (EUR) (12/2014) 2.3400
Est. PEG Ratio -
Market Cap (M EUR) 1,195.98
Shares Outstanding (M) 6.60
30 Day Average Volume 14,260
Price/Book (mrq) 2.5291
Price/Sale (ttm) 2.2320
Dividend Indicated Gross Yield 0.68%
Cash Dividend (EUR) 0.6300
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth 11.89%
Next Earnings Announcement 03/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIO3

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BIO3

Biotest AG develops, produces and markets pharmaceuticals, as well as diagnostic and testing products and equipment for human and veterinarian applications. The Company provides a wide range of immune, molecular-biological and antibody test systems, as well as medical test devices. Biotest manages research and production operations mainly in Europe and sells its products worldwide.

Gregor SchulzChairman-Mgmt BoardBernhard EhmerMember-Exec Board
Michael RamrothCFO/Member-Mgmt BoardGeorg FlossMember-Mgmt Board
More Company Profile & Key Executives for BIO3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil